Press Release Alkeus Announces $150 Million Series B Financing, Supporting Rapid Registration Path for gildeuretinol (ALK-001) in the Treatment of Stargardt Disease Vertex Founder and Industry Pioneer Joshua Boger, Ph.D. named as Executive Chairman of Alkeus June 5,...
EXPANDED ACCESS POLICY This policy provides general information on how to request access to Alkeus Pharmaceuticals, Inc. (“Alkeus Pharmaceuticals” or “Alkeus”) investigational drugs prior to their commercial availability (“expanded...
